サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1390672

組み換えDNA技術市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Recombinant DNA Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 149 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.97円
組み換えDNA技術市場：世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年11月24日
発行: IMARC
ページ情報: 英文 149 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

組み換えDNA技術の世界市場規模は、2022年に7,298億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに9,668億米ドルに達し、2022年から2028年にかけて4.80%の成長率（CAGR）を示すと予測しています。

組み換えDNA技術の登場は、生物学の発展に革命をもたらし、技術革新の新たな機会を提供しました。遺伝子工学としても知られるこの技術は、現在、生物体外の遺伝物質を改変し、生物体において改良された望ましい特性を得るために広く利用されています。これには、適切なベクターを通して、望ましい遺伝子配列を持つDNA断片を複数の供給源から挿入することが含まれます。これに加えて、食用や健康上の問題に対処するために必要な重要なタンパク質を、安全かつ手頃な価格で十分に生産することができます。その結果、DNA組み換え技術は学際的な応用が可能であり、健康を改善し、食糧資源と多様な環境への悪影響に対する抵抗力を強化する顕著な可能性を秘めています。

組み換えDNA技術の市場動向：

組み換えDNA技術は、主に新しいワクチンや医薬品の開発によって、さまざまな健康状態を改善するために利用されています。これは、診断キット、モニタリング装置、新しい治療アプローチの開発による治療戦略の改善と相まって、市場の成長を促す主な要因の一つとなっています。さらに、遺伝子組み換え生物（GMO）に関する調査も増加しており、これには生物分解物質やクリーン燃料生産物質とみなされる微生物が含まれます。この背景には、急速な都市化、世界人口の増加、耕地の減少、食糧不足の深刻化、遺伝子組み換え作物の採用増加などがあります。これとは別に、組み換えDNA技術は医療遺伝学や生物医学において、即効性のある膨大な治療製品を開発する革新的な機会をいくつも提供するため、その応用はさまざまな分野で拡大しています。例えば、組み換えDNA技術と、欠陥遺伝子を正常な遺伝子に置き換えるための効果的な遺伝子治療との統合や、臨床研究、調査、疾病診断のための抗原特異的抗体の生産は、今後数年間の市場成長を促進すると予想されます。

本レポートで扱う主な質問

  • 組み換えDNA技術の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • COVID-19が世界の組み換えDNA技術市場に与えた影響は？
  • 主要な地域市場は？
  • 製品別の市場内訳は？
  • 成分別の市場内訳は？
  • 用途別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主要な促進要因と課題は何か？
  • 世界の組み換えDNA技術市場の構造と主要プレーヤーは？
  • 業界における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の組み換えDNA技術市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品別

  • 医療
    • 市場動向
    • 主要セグメント
      • 治療薬
      • ヒトタンパク質
      • ワクチン
    • 市場予測
  • 非医薬品
    • 市場動向
    • 主要セグメント
      • バイオ作物
      • 特殊化学品
      • その他
    • 市場予測

第7章 市場内訳：コンポーネント別

  • 発現システム
    • 市場動向
    • 市場予測
  • クローニングベクター
    • 市場動向
    • 市場予測

第8章 市場内訳：用途別

  • 食品・農業
    • 市場動向
    • 市場予測
  • 健康・疾病
    • 市場動向
    • 市場予測
  • 環境
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：エンドユーザー別

  • バイオ・製薬企業
    • 市場動向
    • 市場予測
  • 学術・政府研究機関
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Amgen Inc
    • Cibus
    • F.Hoffmann-La Roche Ltd
    • GenScript
    • GlaxoSmithKline plc.
    • Horizon Discovery Group plc
    • Merck KGaA
    • New England Biolabs
    • Novo Nordisk A/S
    • Pfizer Inc.
    • Sanofi S.A
    • Syngene International Ltd（Biocon Limited）
図表

List of Figures

  • Figure 1: Global: Recombinant DNA Technology Market: Major Drivers and Challenges
  • Figure 2: Global: Recombinant DNA Technology Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Recombinant DNA Technology Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Recombinant DNA Technology Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Recombinant DNA Technology Market: Breakup by Component (in %), 2022
  • Figure 6: Global: Recombinant DNA Technology Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Recombinant DNA Technology Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Recombinant DNA Technology Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Recombinant DNA Technology (Medical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Recombinant DNA Technology (Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Recombinant DNA Technology (Non-Medical) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Recombinant DNA Technology (Non-Medical) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Recombinant DNA Technology (Expression System) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Recombinant DNA Technology (Expression System) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Recombinant DNA Technology (Cloning Vector) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Recombinant DNA Technology (Cloning Vector) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Recombinant DNA Technology (Food and Agriculture) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Recombinant DNA Technology (Food and Agriculture) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Recombinant DNA Technology (Health and Disease) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Recombinant DNA Technology (Health and Disease) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Recombinant DNA Technology (Environment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Recombinant DNA Technology (Environment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Recombinant DNA Technology (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Recombinant DNA Technology (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Recombinant DNA Technology (Biotechnology and Pharmaceutical Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Recombinant DNA Technology (Academic and Government Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Recombinant DNA Technology (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Recombinant DNA Technology (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: North America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Asia-Pacific: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Asia-Pacific: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: China: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: China: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Japan: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Japan: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: India: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: India: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: South Korea: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: South Korea: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Australia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Australia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Indonesia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Indonesia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Europe: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Europe: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Germany: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Germany: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: France: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: France: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: United Kingdom: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: United Kingdom: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Italy: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Italy: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Spain: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Spain: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Russia: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Russia: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Latin America: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Latin America: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Brazil: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Brazil: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Mexico: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Mexico: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Middle East and Africa: Recombinant DNA Technology Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Middle East and Africa: Recombinant DNA Technology Market: Breakup by Country (in %), 2022
  • Figure 79: Middle East and Africa: Recombinant DNA Technology Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Recombinant DNA Technology Industry: SWOT Analysis
  • Figure 81: Global: Recombinant DNA Technology Industry: Value Chain Analysis
  • Figure 82: Global: Recombinant DNA Technology Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Recombinant DNA Technology Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Recombinant DNA Technology Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Recombinant DNA Technology Market Forecast: Breakup by Component (in Million US$), 2023-2028
  • Table 4: Global: Recombinant DNA Technology Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Recombinant DNA Technology Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Recombinant DNA Technology Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Recombinant DNA Technology Market: Competitive Structure
  • Table 8: Global: Recombinant DNA Technology Market: Key Players
目次
Product Code: SR112023A4484

Abstract

The global recombinant DNA technology market size reached US$ 729.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 966.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.80% during 2022-2028.

The advent of recombinant DNA technology has revolutionized development in biology and offered new opportunities for innovations. Also known as genetic engineering, it is currently widely used to alter genetic material outside an organism and obtain improved and desired characteristics in living organisms. It includes the insertion of DNA fragments from several sources that have a desirable gene sequence through an appropriate vector. Besides this, it assists in the safe, affordable, and sufficient production of vital proteins required for dietary purposes and fighting health problems. As a result, it has multidisciplinary applications and a remarkable potential to improve health and enhance food resources and resistance to divergent adverse environmental effects.

Recombinant DNA Technology Market Trends:

The recombinant DNA technology is utilized for improving different health conditions, mainly by developing new vaccines and pharmaceuticals. This, coupled with the improving treatment strategies on account of the developing diagnostics kits, monitoring devices, and new therapeutic approaches, represents one of the key factors impelling the growth of the market. Moreover, there is a rise in the research conducted on genetically modified organisms (GMO), which include microorganisms that are considered as bio degraders and clean fuel producers. This can be accredited to rapid urbanization, growing global population, reducing arable land, considerable rising food shortage and increasing adoption of GMO crops. Apart from this, as recombinant DNA technology offers several innovation opportunities to develop a vast range of therapeutic products with immediate effect in medical genetics and biomedicine, its application is expanding in various sectors. For instance, the integration of recombinant DNA technology with effective gene therapy for replacing the defective gene with normal ones and the production of antigen-specific antibodies for clinical research, studies, and disease diagnosis, are anticipated to drive the market growth in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global recombinant DNA technology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, component, application and end user.

Breakup by Product:

Medical

Therapeutic Agent

Human Protein

Vaccines

Non-Medical

Biotech Crops

Specialty Chemicals

Others

Breakup by Component:

Expression System

Cloning Vector

Breakup by Application:

Food and Agriculture

Health and Disease

Environment

Others

Breakup by End User:

Biotechnology and Pharmaceutical Companies

Academic and Government Research Institutes

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc, Cibus, F.Hoffmann-La Roche Ltd, GenScript, GlaxoSmithKline plc., Horizon Discovery Group plc, Merck KGaA, New England Biolabs, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A and Syngene International Ltd (Biocon Limited).

Key Questions Answered in This Report:

  • How has the global recombinant DNA technology market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global recombinant DNA technology market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global recombinant DNA technology market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Recombinant DNA Technology Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Medical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Therapeutic Agent
      • 6.1.2.2 Human Protein
      • 6.1.2.3 Vaccines
    • 6.1.3 Market Forecast
  • 6.2 Non-Medical
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Biotech Crops
      • 6.2.2.2 Specialty Chemicals
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Component

  • 7.1 Expression System
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cloning Vector
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Food and Agriculture
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Health and Disease
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Environment
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Biotechnology and Pharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Government Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Amgen Inc
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Cibus
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 F.Hoffmann-La Roche Ltd
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 SWOT Analysis
    • 15.3.4 GenScript
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 GlaxoSmithKline plc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Horizon Discovery Group plc
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 New England Biolabs
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Novo Nordisk A/S
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Pfizer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sanofi S.A
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Syngene International Ltd (Biocon Limited)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis